Current advances and future visions on bioelectronic immunosensing for prostate-specific antigen

Early cancer diagnosis remains the holy-grail in the battle against cancers progression. Tainted with debates and medical challenges, current therapeutic approaches for prostate cancer (PCa) lack early preventive measures, rapid diagnostic capabilities, risk factors identification, and portability,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biosensors & bioelectronics 2017-12, Vol.98, p.267-284
Hauptverfasser: Ibau, Conlathan, Md Arshad, M.K., Gopinath, Subash C.B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 284
container_issue
container_start_page 267
container_title Biosensors & bioelectronics
container_volume 98
creator Ibau, Conlathan
Md Arshad, M.K.
Gopinath, Subash C.B.
description Early cancer diagnosis remains the holy-grail in the battle against cancers progression. Tainted with debates and medical challenges, current therapeutic approaches for prostate cancer (PCa) lack early preventive measures, rapid diagnostic capabilities, risk factors identification, and portability, i.e. the inherent attributes offered by the label-free biosensing devices. Electronic assisted immunosensing systems inherit the high sensitivity and specificity properties due to the predilection of the antigen–antibody affinity. Bioelectronic immunosensor for PCa has attracted much attentions among the researchers due to its high-performance, easy to prepare, rapid feedback, and possibility for miniaturization. This review explores the current advances on bioelectronic immunosensors for the detection of PCa biomarker revealed in the past decade. The research milestones and current trends of the immunosensors are reported to project the future visions in order to propel their “lab-to-market” realization. [Display omitted] •A concise review on immunosensor for prostate cancer's detection is presented.•The field-effect transistors and customized-electrodes devices-based sensors offer the highest LODs and portability.•The future visions of prostate-specific antigen (PSA) biosensing are discussed.
doi_str_mv 10.1016/j.bios.2017.06.049
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1917665559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0956566317304347</els_id><sourcerecordid>1917665559</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-490d8301eae4d90f66163b7911071b1e06cbd032580c97e7129f6300447c0ff83</originalsourceid><addsrcrecordid>eNp9kE1P4zAQhq0Vq235-AMckI9cEsZx4sQSF1TBglSJC3v2Os4YuWrsYieV-PfrqoXjnubyzDvvPIRcMygZMHG3KXsXUlkBa0sQJdTyB1myruVFXfHmjCxBNqJohOALcp7SBgBaJuEXWVSd6CRjfEn-ruYY0U9UD3vtDSaq_UDtPM0R6d4lF3yiwdN8Cbdophi8M9SN4-xDQp-cf6c2RLqLIU16wiLt0DibGe0n947-kvy0epvw6jQvyJ-nx7fVc7F-_f2yelgXhjdiKmoJQ8eBocZ6kGCFYIL3bS6ZO_cMQZh-AF41HRjZYssqaQUHqOvWgLUdvyC3x9zc5GPGNKnRJYPbrfYY5qSYZK0QTdPIjFZH1OTSKaJVu-hGHT8VA3UwqzbqYFYdzCoQKpvNSzen_Lkfcfhe-VKZgfsjgPnLvcOoknGYlQ4uZnFqCO5_-f8APm-K-g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1917665559</pqid></control><display><type>article</type><title>Current advances and future visions on bioelectronic immunosensing for prostate-specific antigen</title><source>MEDLINE</source><source>ScienceDirect Freedom Collection (Elsevier)</source><creator>Ibau, Conlathan ; Md Arshad, M.K. ; Gopinath, Subash C.B.</creator><creatorcontrib>Ibau, Conlathan ; Md Arshad, M.K. ; Gopinath, Subash C.B.</creatorcontrib><description>Early cancer diagnosis remains the holy-grail in the battle against cancers progression. Tainted with debates and medical challenges, current therapeutic approaches for prostate cancer (PCa) lack early preventive measures, rapid diagnostic capabilities, risk factors identification, and portability, i.e. the inherent attributes offered by the label-free biosensing devices. Electronic assisted immunosensing systems inherit the high sensitivity and specificity properties due to the predilection of the antigen–antibody affinity. Bioelectronic immunosensor for PCa has attracted much attentions among the researchers due to its high-performance, easy to prepare, rapid feedback, and possibility for miniaturization. This review explores the current advances on bioelectronic immunosensors for the detection of PCa biomarker revealed in the past decade. The research milestones and current trends of the immunosensors are reported to project the future visions in order to propel their “lab-to-market” realization. [Display omitted] •A concise review on immunosensor for prostate cancer's detection is presented.•The field-effect transistors and customized-electrodes devices-based sensors offer the highest LODs and portability.•The future visions of prostate-specific antigen (PSA) biosensing are discussed.</description><identifier>ISSN: 0956-5663</identifier><identifier>EISSN: 1873-4235</identifier><identifier>DOI: 10.1016/j.bios.2017.06.049</identifier><identifier>PMID: 28689113</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Bioelectronic ; Biosensing Techniques ; Biosensor ; Early Detection of Cancer ; Humans ; Immunosensors ; Male ; Prostate cancer ; Prostate-specific antigen ; Prostate-Specific Antigen - blood ; Prostate-Specific Antigen - isolation &amp; purification ; Prostatic Neoplasms - blood</subject><ispartof>Biosensors &amp; bioelectronics, 2017-12, Vol.98, p.267-284</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-490d8301eae4d90f66163b7911071b1e06cbd032580c97e7129f6300447c0ff83</citedby><cites>FETCH-LOGICAL-c356t-490d8301eae4d90f66163b7911071b1e06cbd032580c97e7129f6300447c0ff83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bios.2017.06.049$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28689113$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ibau, Conlathan</creatorcontrib><creatorcontrib>Md Arshad, M.K.</creatorcontrib><creatorcontrib>Gopinath, Subash C.B.</creatorcontrib><title>Current advances and future visions on bioelectronic immunosensing for prostate-specific antigen</title><title>Biosensors &amp; bioelectronics</title><addtitle>Biosens Bioelectron</addtitle><description>Early cancer diagnosis remains the holy-grail in the battle against cancers progression. Tainted with debates and medical challenges, current therapeutic approaches for prostate cancer (PCa) lack early preventive measures, rapid diagnostic capabilities, risk factors identification, and portability, i.e. the inherent attributes offered by the label-free biosensing devices. Electronic assisted immunosensing systems inherit the high sensitivity and specificity properties due to the predilection of the antigen–antibody affinity. Bioelectronic immunosensor for PCa has attracted much attentions among the researchers due to its high-performance, easy to prepare, rapid feedback, and possibility for miniaturization. This review explores the current advances on bioelectronic immunosensors for the detection of PCa biomarker revealed in the past decade. The research milestones and current trends of the immunosensors are reported to project the future visions in order to propel their “lab-to-market” realization. [Display omitted] •A concise review on immunosensor for prostate cancer's detection is presented.•The field-effect transistors and customized-electrodes devices-based sensors offer the highest LODs and portability.•The future visions of prostate-specific antigen (PSA) biosensing are discussed.</description><subject>Bioelectronic</subject><subject>Biosensing Techniques</subject><subject>Biosensor</subject><subject>Early Detection of Cancer</subject><subject>Humans</subject><subject>Immunosensors</subject><subject>Male</subject><subject>Prostate cancer</subject><subject>Prostate-specific antigen</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostate-Specific Antigen - isolation &amp; purification</subject><subject>Prostatic Neoplasms - blood</subject><issn>0956-5663</issn><issn>1873-4235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1P4zAQhq0Vq235-AMckI9cEsZx4sQSF1TBglSJC3v2Os4YuWrsYieV-PfrqoXjnubyzDvvPIRcMygZMHG3KXsXUlkBa0sQJdTyB1myruVFXfHmjCxBNqJohOALcp7SBgBaJuEXWVSd6CRjfEn-ruYY0U9UD3vtDSaq_UDtPM0R6d4lF3yiwdN8Cbdophi8M9SN4-xDQp-cf6c2RLqLIU16wiLt0DibGe0n947-kvy0epvw6jQvyJ-nx7fVc7F-_f2yelgXhjdiKmoJQ8eBocZ6kGCFYIL3bS6ZO_cMQZh-AF41HRjZYssqaQUHqOvWgLUdvyC3x9zc5GPGNKnRJYPbrfYY5qSYZK0QTdPIjFZH1OTSKaJVu-hGHT8VA3UwqzbqYFYdzCoQKpvNSzen_Lkfcfhe-VKZgfsjgPnLvcOoknGYlQ4uZnFqCO5_-f8APm-K-g</recordid><startdate>20171215</startdate><enddate>20171215</enddate><creator>Ibau, Conlathan</creator><creator>Md Arshad, M.K.</creator><creator>Gopinath, Subash C.B.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20171215</creationdate><title>Current advances and future visions on bioelectronic immunosensing for prostate-specific antigen</title><author>Ibau, Conlathan ; Md Arshad, M.K. ; Gopinath, Subash C.B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-490d8301eae4d90f66163b7911071b1e06cbd032580c97e7129f6300447c0ff83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Bioelectronic</topic><topic>Biosensing Techniques</topic><topic>Biosensor</topic><topic>Early Detection of Cancer</topic><topic>Humans</topic><topic>Immunosensors</topic><topic>Male</topic><topic>Prostate cancer</topic><topic>Prostate-specific antigen</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostate-Specific Antigen - isolation &amp; purification</topic><topic>Prostatic Neoplasms - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ibau, Conlathan</creatorcontrib><creatorcontrib>Md Arshad, M.K.</creatorcontrib><creatorcontrib>Gopinath, Subash C.B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biosensors &amp; bioelectronics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ibau, Conlathan</au><au>Md Arshad, M.K.</au><au>Gopinath, Subash C.B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current advances and future visions on bioelectronic immunosensing for prostate-specific antigen</atitle><jtitle>Biosensors &amp; bioelectronics</jtitle><addtitle>Biosens Bioelectron</addtitle><date>2017-12-15</date><risdate>2017</risdate><volume>98</volume><spage>267</spage><epage>284</epage><pages>267-284</pages><issn>0956-5663</issn><eissn>1873-4235</eissn><abstract>Early cancer diagnosis remains the holy-grail in the battle against cancers progression. Tainted with debates and medical challenges, current therapeutic approaches for prostate cancer (PCa) lack early preventive measures, rapid diagnostic capabilities, risk factors identification, and portability, i.e. the inherent attributes offered by the label-free biosensing devices. Electronic assisted immunosensing systems inherit the high sensitivity and specificity properties due to the predilection of the antigen–antibody affinity. Bioelectronic immunosensor for PCa has attracted much attentions among the researchers due to its high-performance, easy to prepare, rapid feedback, and possibility for miniaturization. This review explores the current advances on bioelectronic immunosensors for the detection of PCa biomarker revealed in the past decade. The research milestones and current trends of the immunosensors are reported to project the future visions in order to propel their “lab-to-market” realization. [Display omitted] •A concise review on immunosensor for prostate cancer's detection is presented.•The field-effect transistors and customized-electrodes devices-based sensors offer the highest LODs and portability.•The future visions of prostate-specific antigen (PSA) biosensing are discussed.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>28689113</pmid><doi>10.1016/j.bios.2017.06.049</doi><tpages>18</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0956-5663
ispartof Biosensors & bioelectronics, 2017-12, Vol.98, p.267-284
issn 0956-5663
1873-4235
language eng
recordid cdi_proquest_miscellaneous_1917665559
source MEDLINE; ScienceDirect Freedom Collection (Elsevier)
subjects Bioelectronic
Biosensing Techniques
Biosensor
Early Detection of Cancer
Humans
Immunosensors
Male
Prostate cancer
Prostate-specific antigen
Prostate-Specific Antigen - blood
Prostate-Specific Antigen - isolation & purification
Prostatic Neoplasms - blood
title Current advances and future visions on bioelectronic immunosensing for prostate-specific antigen
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A54%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20advances%20and%20future%20visions%20on%20bioelectronic%20immunosensing%20for%20prostate-specific%20antigen&rft.jtitle=Biosensors%20&%20bioelectronics&rft.au=Ibau,%20Conlathan&rft.date=2017-12-15&rft.volume=98&rft.spage=267&rft.epage=284&rft.pages=267-284&rft.issn=0956-5663&rft.eissn=1873-4235&rft_id=info:doi/10.1016/j.bios.2017.06.049&rft_dat=%3Cproquest_cross%3E1917665559%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1917665559&rft_id=info:pmid/28689113&rft_els_id=S0956566317304347&rfr_iscdi=true